• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 12.09
  • VXN 15.15
  • VXO 12.04
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





NO
Refresh      
HSIC (Henry Schein Inc.)
Last Trade 61.5 Dividend/Share 0 PE Ratio 14.86
Date April 18-2019 Dividend Yield 0.000 Return on Assets 6.55
Change 0.77 ExDividend Date 0 Return on Capital null
Bid null Latest EPS 3.49 Price/Sale 0.909
Ask null LatestEPS Date 2018-12-31 Price to Book 3.1
Volume null EPS ttm 4.140 Institutional % 148.2
Avg Volume 1.43M Shares Outstanding 149.47M Insider % 1.4
Open 61.03 Float 147.39M Short Ratio null
Prev Close 60.73 Return On Equity 18.57 5 Year Change % 0.077
High 62.1 Consensus EPS 0.76 2 Year Change % -0.268
Low 60.105 No. of Estimate 8.000 1 Year Change % -0.167
52 Week High 91.35 EPS Surprise $ null YTD Change % -0.195
52 Week Low 56.58 EPS Surprise Percent 0 6 Month Change % -0.250
52 Week Change -13.295 EBITDA 0M 3 Month Change % -0.206
50 Day MA 60.6842 Revenue 0M 1 Month Change % 0.005
200 Day MA Gross Profit 0M 5 Day Change % -0.005
Market Cap 9192.49M Cash 0M 30 Day Change % 0.050
Beta 0.802505 Debt 0M Stock Exchange Nasdaq Global Select
Sector Healthcare Revenue Per Share 0 Short Interest 0
Short Date 0 Revenue Per Employee 0 Short Ratio null
Data courtesy of IEX
Company Profile

Henry Schein, Inc. distributes healthcare products and services primarily to office-based healthcare practitioners. It operates in two segments, Healthcare Distribution and Technology. The Healthcare Distribution segment offers consumable dental products, dental laboratory products, and small equipment, including X-ray products, infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, and abrasives; and large dental equipment comprising dental chairs, delivery units and lights, X-ray equipment, equipment repair, and high-tech equipment. It also provides medical products, including branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins; and animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment. The Technology segment offers software and related products, and value-added solutions that primarily include practice management software systems for dental and medical practitioners and animal health clinics. Its services also consist of financial services and continuing education services for practitioners. Henry Schein primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government and other institutions. It operates in the United States, Australia, Austria, Belgium, Canada, the People?s Republic of China, the Czech Republic, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, New Zealand, Portugal, Slovakia, Spain, Switzerland, the United Kingdom, Iceland, Israel, Saudi Arabia, and the United Arab Emirates. The company was founded in 1992 and is headquartered in Melville, New York.